BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37697668)

  • 1. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in esophagogastric cancer patients.
    Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Katoh N; Okimoto T; Suzuki M; Sakurai H
    J Radiat Res; 2023 Nov; 64(6):926-932. PubMed ID: 37697668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in breast cancer patients.
    Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Okimoto T; Ogino T; Suzuki M; Murayama S
    J Radiat Res; 2024 Mar; 65(2):231-237. PubMed ID: 38321606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of proton beam therapy for liver oligometastatic recurrence in patients with postoperative esophagus cancer.
    Yamaguchi H; Kato T; Honda M; Hamada K; Seto I; Tominaga T; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M
    J Radiat Res; 2023 May; 64(3):582-589. PubMed ID: 36913708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Beam Therapy for Lung Oligometastatic Recurrence in Patients With Esophageal Cancer.
    Yamaguchi H; Kato T; Honda M; Hamada K; Ishikawa Y; Seto I; Takagawa Y; Suzuki M; Kikuchi Y; Murakami M
    Cureus; 2023 Dec; 15(12):e50343. PubMed ID: 38205500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Endoscopic Evaluation of Acute Radiation Esophagitis during Chemoradiotherapy with Proton Beam Therapy Boost for Esophageal Cancer.
    Hasatani K; Tamamura H; Yamamoto K; Aoyagi H; Miyanaga T; Kaizaki Y; Sawada T
    Digestion; 2020; 101(4):366-374. PubMed ID: 31067539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
    Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
    Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
    Shiraishi Y; Xu C; Yang J; Komaki R; Lin SH
    Radiother Oncol; 2017 Oct; 125(1):48-54. PubMed ID: 28917586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.
    Fernandes A; Berman AT; Mick R; Both S; Lelionis K; Lukens JN; Ben-Josef E; Metz JM; Plastaras JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):483-487. PubMed ID: 26847847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer.
    Yamaguchi H; Kato T; Honda M; Hamada K; Todate Y; Ishikawa Y; Seto I; Tominaga T; Machida M; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M; Konno S
    Strahlenther Onkol; 2023 Mar; 199(3):304-312. PubMed ID: 36446925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors.
    Gentile MS; Yeap BY; Paganetti H; Goebel CP; Gaudet DE; Gallotto SL; Weyman EA; Morgan ML; MacDonald SM; Giantsoudi D; Adams J; Tarbell NJ; Kooy H; Yock TI
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):719-729. PubMed ID: 29413284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton beam therapy for liver metastases from gastric cancer.
    Fukumitsu N; Okumura T; Takizawa D; Numajiri H; Ohnishi K; Mizumoto M; Aihara T; Ishikawa H; Tsuboi K; Sakurai H
    J Radiat Res; 2017 May; 58(3):357-362. PubMed ID: 27974509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Japanese registry study and systematic review of particle therapy for renal cell carcinoma.
    Ishikawa H; Arimura T; Maruo K; Kawamura H; Toyama S; Ogino T; Okimoto T; Murakami M; Sato Y; Nishioka K; Araya M; Ohba H; Umehara K; Aoyama H; Obara W; Azuma H; Tsuji H; Sakurai H
    J Radiat Res; 2023 Jun; 64(Supplement_1):i41-i48. PubMed ID: 37045797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis.
    Thorpe CS; Niska JR; Girardo ME; Kosiorek HE; McGee LA; Hartsell WF; Larson GL; Tsai HK; Rossi CJ; Rosen LR; Vargas CE
    Breast J; 2019 Nov; 25(6):1160-1170. PubMed ID: 31338974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of proton beam therapy for liver metastatic recurrence in gastric cancer patients.
    Yamaguchi H; Honda M; Hamada K; Kobayashi H; Todate Y; Seto I; Takayama K; Suzuki M; Wada H; Kikuchi Y; Murakami M
    Jpn J Clin Oncol; 2020 Aug; 50(8):903-908. PubMed ID: 32363379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.
    Gomez DR; Gillin M; Liao Z; Wei C; Lin SH; Swanick C; Alvarado T; Komaki R; Cox JD; Chang JY
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):665-70. PubMed ID: 23688815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan.
    Mizumoto M; Ogino H; Okumura T; Terashima K; Murakami M; Ogino T; Tamamura H; Akimoto T; Waki T; Katoh N; Araya M; Onoe T; Takagi M; Iwata H; Numajiri H; Okimoto T; Uchinami Y; Maruo K; Shibuya K; Sakurai H
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):725-733. PubMed ID: 37778422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.
    Volpe S; Piperno G; Colombo F; Biffi A; Comi S; Mastroleo F; Maria Camarda A; Casbarra A; Cattani F; Corrao G; de Marinis F; Spaggiari L; Guckenberger M; Orecchia R; Alterio D; Jereczek-Fossa BA
    Cancer Treat Rev; 2022 Nov; 110():102464. PubMed ID: 36194908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.
    Ono T; Hareyama M; Nakamura T; Kimura K; Hayashi Y; Azami Y; Hirose K; Hatayama Y; Suzuki M; Wada H; Kikuchi Y; Nemoto K
    Radiat Oncol; 2016 Apr; 11():56. PubMed ID: 27090216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical results of proton beam radiotherapy for inoperable stage III non-small cell lung cancer: a Japanese national registry study.
    Tatebe H; Harada H; Mori K; Iwata H; Akimoto T; Murakami M; Waki T; Ogino T; Nakamura M; Taguchi H; Nakayama H; Satouchi M; Aoyama H
    J Radiat Res; 2023 Jun; 64(Supplement_1):i8-i15. PubMed ID: 37137157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.